Solid Biosciences (SLDB) Return on Capital Employed Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 2,503.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -105.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 2,400.00 |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -588.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -588.00 |
| Dec 31, 2025 | -523.00 |
| Sep 30, 2025 | -1,015.00 |
| Jun 30, 2025 | -851.00 |
| Mar 31, 2025 | -870.00 |
| Dec 31, 2024 | -1,129.00 |
| Sep 30, 2024 | 869.00 |
| Jun 30, 2024 | 1,249.00 |
| Mar 31, 2024 | -112.00 |
| Dec 31, 2023 | -1,176.00 |
| Sep 30, 2023 | -1,472.00 |
| Jun 30, 2023 | -999.00 |
| Mar 31, 2023 | -962.00 |
| Dec 31, 2022 | -1,998.00 |
| Sep 30, 2022 | -1,851.00 |
| Jun 30, 2022 | -1,605.00 |
| Mar 31, 2022 | -255.00 |
| Dec 31, 2021 | 7,537.00 |
| Sep 30, 2021 | 25,638.00 |
| Jun 30, 2021 | 17,346.00 |
| Mar 31, 2021 | 11,461.00 |
| Dec 31, 2020 | 1,196.00 |
| Sep 30, 2020 | -17,537.00 |
| Jun 30, 2020 | -9,989.00 |
| Mar 31, 2020 | -7,476.00 |
| Dec 31, 2019 | -6,485.00 |
| Sep 30, 2019 | -6,831.00 |
| Jun 30, 2019 | -6,775.00 |
| Mar 31, 2019 | -3,185.00 |